Evidence map›Paper›PMID 16269264›Full record

ArticleMicrobes and infection2005

Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus.

Masanobu Yamate, Makiko Yamashita, Toshiyuki Goto, Shoutaro Tsuji, Yong-Gang Li, Jiranan Warachit, Mikihiro Yunoki, Kazuyoshi Ikuta

Abstract read
In one paragraph

Article in Microbes and infection, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Choosing a cellular model to study SARS-CoV-2.Frontiers in cellular and infection microbiology · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Mechanisms of establishment of persistent SARS-CoV-infected cells.Biochemical and biophysical research communications · 2006
    Article
  16. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).Perspectives in medical virology · 2006
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Masanobu YamateDepartment of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Makiko Yamashita
Toshiyuki Goto
Shoutaro Tsuji
Yong-Gang Li
Jiranan Warachit
Mikihiro Yunoki
Kazuyoshi Ikuta
The University of Osaka · JPKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little information is available on persistent infection of severe acute respiratory syndrome (SARS) coronavirus (CoV). In this study, we established persistent infection of SARS-CoV in the Vero E6 cell line. Acute infection of Vero E6 with SARS-CoV produced a lytic infection with characteristic rounding cytopathic effects (CPE) and the production of a large number of infectious particles in the culture fluid within 3 days post-infection. Upon subsequent culturing of the remaining adherent cells, the cells gradually proliferated and recovered normal morphology similar to that of the parental cells, and continued to produce large numbers of infectious viral particles during the observation period of 5 months. Among a total of 87 cell clones obtained from the persistently infected Vero E6, only four cell clones (named #13, #18, #21, and #34) were positive for viral RNA. Clones #13, #18, and #34 shifted to viral RNA-negative during subsequent cultures, while #21 continuously produced infectious particles at a high rate. The SARS-CoV receptor, angiotensin-converting enzyme 2, was almost completely down regulated from the cell surface of persistently infected cells. Western blot analysis as well as electron microscopy indicated that the ratios of spike to nucleocapsid protein in clone #21 as well as its parental persistently infected cells were lower than that in the cells in the acute phase of infection. These Vero E6 cells persistently infected with SARS-CoV may be useful for clarifying the mechanism of the persistent infection and also for elucidating the possible pathophysiologic significance of such long-term maintenance of this virus.

Indexed as

Angiotensin-Converting Enzyme 2AnimalsAntigens, SurfaceBlotting, WesternCarboxypeptidasesChlorocebus aethiopsCytopathogenic Effect, ViralDown-RegulationFlow CytometryMembrane GlycoproteinsMicroscopy, ConfocalMicroscopy, ElectronMicroscopy, FluorescenceNucleocapsid ProteinsPeptidyl-Dipeptidase ARNA, ViralAngiotensin-Converting Enzyme 2Antigens, SurfaceCarboxypeptidasesMembrane GlycoproteinsNucleocapsid ProteinsPeptidyl-Dipeptidase ARNA, ViralSpike Glycoprotein, Coronavirusspike glycoprotein, SARS-CoVViral Envelope Proteins

Identifiers

PMID16269264
PMCPMC7110502
OpenAlexW2024166835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.